Rinossinusite fúngica invasiva por mucormicose associada ao uso abusivo de corticosteróides: relato de caso

Autores

  • João Ricardo Ramos Rosa Faculdade de Ciências Médicas da Santa Casa São Paulo (FCMSCSP), São Paulo, SP. Brasil. https://orcid.org/0009-0008-7053-8187
  • Carolline Siqueira Lembo Faculdade de Ciências Médicas da Santa Casa São Paulo (FCMSCSP), São Paulo, SP. Brasil. https://orcid.org/0009-0005-7506-0635
  • Isabella Marques da Silva Faculdade de Ciências Médicas da Santa Casa São Paulo (FCMSCSP), São Paulo, SP. Brasil.
  • Júlia Rodrigues da Silva Faculdade de Ciências Médicas da Santa Casa São Paulo (FCMSCSP), São Paulo, SP. Brasil.

DOI:

https://doi.org/10.11606/issn.1679-9836.v104iesp.e-249403

Palavras-chave:

Mucormicose, Rinossinusite, Corticosteróides

Resumo

INTRODUCTION

 

Mucormycosis is a rare invasive disease caused by fungi of the order Mucorales, with the genus Rhizopus spp being the most common [1]. It is predominantly found in immunosuppressed patients, such as those with diabetes mellitus [2]. The infection has two main forms: the rhino-orbito-cerebral form, which is more prevalent and leads to ocular inflammation, facial pain and even brain involvement; and the pulmonary form, which is less common [2]. It is noted that hyperglycemia provides an environment for the proliferation of fungi, while compromising the immune system, making the patient more susceptible to infection [3]. Finally, it can be mentioned that the abuse of corticosteroids aggravates this scenario by causing both immunosuppression and increased blood glucose levels.

 

OBJECTIVES  

Primary: To evaluate the negative effect of the abusive use of corticosteroids on the worsening of the clinical picture of mucormycosis.

Secondary: To report a case of an uncommon infection by a species of fungus in an immunosuppressed patient.

Downloads

Os dados de download ainda não estão disponíveis.

Referências

1. Steinbrink JM, Miceli MH. Mucormycosis. Infect Dis Clin North Am. 2021;35(2):435-52. Doi: 10.1016/j.idc.2021.03.009.

2. Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DCM, Chen SC. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019;25(1):26-34. Doi: 10.1016/j.cmi.2018.07.011.

3. Pilmis B, Alanio A, Lortholary O, Lanternier F. Recent advances in the understanding and management of mucormycosis. F1000Res. 2018;7:F1000 Faculty Rev-1429. Doi: 10.12688/f1000research.15081.1.

Downloads

Publicado

2026-07-20

Edição

Seção

Relato de Caso/Case Report

Como Citar

Rosa, J. R. R., Lembo, C. S., Silva, I. M. da, & Silva, J. R. da. (2026). Rinossinusite fúngica invasiva por mucormicose associada ao uso abusivo de corticosteróides: relato de caso. Revista De Medicina, 104(esp.), e-249403. https://doi.org/10.11606/issn.1679-9836.v104iesp.e-249403